Page breadcrumb nav

VAERS Report 2156907

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (MODERNA))

Type : Coronavirus 2019 vaccine

Fabricant: MODERNA

Lot: 000050a


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-20
Date d’apparition
3
Nombre de jours (date d’apparition – date de vaccination)
3
Description de l’événement indésirable

idiopathic dizziness; this case was received via regulatory authority (reference number: gb-mhra-adr 26652354) on 27-feb-2022 and was forwarded to moderna on 27-feb-2022. this regulatory authority case was reported by a consumer and describes the occurrence of dizziness (idiopathic dizziness) in a female patient of an unknown age who received mrna-1273 (moderna covid-19 vaccine) (batch no. 000050a) for an unknown indication. concomitant products included candesartan and furosemide for hypertension, covid-19 vaccine nrvv ad (chadox1 ncov-19) (covid-19 vaccine astrazeneca) and elasomeran (covid-19 vaccine moderna) for vaccination, influenza vaccine (influenza virus) for an unknown indication. on 20-feb-2022, the patient received third dose of mrna-1273 (moderna covid-19 vaccine) (unknown route) 1 dosage form. on 23-feb-2022, after starting mrna-1273 (moderna covid-19 vaccine), the patient experienced dizziness (idiopathic dizziness) (seriousness criterion medically significant). at the time of the report, dizziness (idiopathic dizziness) had not resolved. the action taken with mrna-1273 (moderna covid-19 vaccine) (unknown) was unknown. no treatment medication reported. patient had not symptoms associated with covid-19 and did not have an covid-19 test. patient had not tested positive for covid-19 since having the vaccine. patient was not enrolled in clinical trial. this report was not related to possible inflammation of the heart (myocarditis or pericarditis). company comment: this regulatory authority case concerns a female patient of unknown age, with history of hypertension, who experienced the serious (medically significant) unexpected event of dizziness 3 days after receiving a dose of mrna-1273. patient previous vaccination schedule included one dose of chadox 1 ncov-19 vaccine and a dose of mrna-1273. patient's history of hypertension treated with candesartan and furosemide remains as a confounder. the benefit-risk relationship of mrna-1273 is not affected by this report.; sender's comments: this regulatory authority case concerns a female patient of unknown age, with history of hypertension, who experienced the serious (medically significant) unexpected event of dizziness 3 days after receiving a dose of mrna-1273. patient previous vaccination schedule included one dose of chadox 1 ncov-19 vaccine and a dose of mrna-1273. patient's history of hypertension treated with candesartan and furosemide remains as a confounder. the benefit-risk relationship of mrna-1273 is not affected by this report

Données de laboratoire
na
Liste des symptômes
dizziness
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na